Velsipity
Product Images NDC 63539-274

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Velsipity (NDC 63539-274). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by U.s. Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Velsipity 01)

Chemical structure diagram showing the molecular configuration of the active ingredient associated with Velsipity. The structure includes distinct aromatic rings, a trifluoromethyl group, carboxylic acid, and amine functional groups, illustrating its chemical composition.*

FDA Label Image

Pfizer Logo (Velsipity 02)

FDA Label Image

Pfizer Logo (Velsipity 03)

FDA Label Image

Principal Display Panel (2 mg Tablet Bottle Label)

Velsipity 2 mg (etrasimod) tablets blister packaging label, containing 28 tablets. The label design features blue and green colors with the Pfizer logo and U.S. Pharmaceuticals noted as the labeler. It includes the product name, active ingredient, strength, and indicates prescription use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.